Senzime's IPO

Senzime raised a round of funding on April 11, 2017. Investors include Public.

Senzime (NASDAQ Stockholm: SEZI) develops patient-oriented monitoring systems that make it possible to assess patients' biochemical and physiological processes before, during, and after surgery. The p…

Articles about Senzime's IPO: